Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Wake Forest University Health Sciences
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02822573
This study is to compare the safety and effects of donepezil (Aricept) for patients reporting cognitive or memory issues after receiving chemotherapy for breast cancer. Patients will receive either donepezil or placebo for 24 weeks. The primary objective is to see if memory improves with the use of donepezil during the study.
Intervention
Donepezil 5 mg, Placebo
Condition
Cognitive Dysfunction, Memory Impairment
Investigators
Stephen R Rapp, PhD